Exécution de notre outil de synthèse sur un nouvel article
Vérifiez l’article ci-dessous, puis lancez sa synthèse.
Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors
Jingxin Ma (Capital Medical University, Beijing Friendship Hospital), Qi Wei (Capital Medical University, National Clinical Research Center for Digestive Diseases), Xin Min Cheng (Capital Medical University, Beijing Friendship Hospital), Jie Zhang (Capital Medical University, Beijing Friendship Hospital), Zhongtao Zhang (Capital Medical University, National Clinical Research Center for Digestive Diseases), Jianrong Su (Capital Medical University, Beijing Friendship Hospital)
Résumé : In recent years, Immune checkpoint inhibitors have been extensively used in the treatment of a variety of cancers. However, the response rates ranging from 13% to 69% depending on the tumor type and the emergence of immune-related adverse events have posed significant challenges for clinical treatment. As a key environmental factor, gut microbes have a variety of important physiological functions such as regulating intestinal nutrient metabolism, promoting intestinal mucosal renewal, and maintaining intestinal mucosal immune activity. A growing number of studies have revealed that gut microbes further influence the anticancer effects of tumor patients through modulation of the efficacy and toxicity of immune checkpoint inhibitors. Currently, faecal microbiota transplantation (FMT) have been developed relatively mature and suggested as an important regulator in order to enhance the efficacy of treatment. This review is dedicated to exploring the impact of differences in flora composition on the efficacy and toxicity of immune checkpoint inhibitors as well as to summarizing the current progress of FMT.